Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

897
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
897
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

822
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
822
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

699
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
699
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

47
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
47
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

81
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
81
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

58
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flashbacks Through Time: Historical Development and Current Use of the Term "Flashback" in Psychedelic and Post-Traumatic Stress Disorder Research.

Psychiatric research and clinical practice·2026
Same author

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Psychotherapy and psychosomatics·2026
Same author

Support factors and barriers in the implementation of an app for refugees in an inpatient psychiatric setting: a qualitative interview study.

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026
Same author

Barriers and Facilitators for the Implementation of an Online Portal in Hospital Mental Health Care: Implementation Study.

JMIR formative research·2026
Same author

Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study.

Psychological medicine·2026
Same author

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

JAMA psychiatry·2026
Same journal

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.

Current topics in behavioral neurosciences·2026
Same journal

Managing Psychological Challenges in the Subacute ("Afterglow") Window of Psychedelic Drug Effects.

Current topics in behavioral neurosciences·2025
Same journal

Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management.

Current topics in behavioral neurosciences·2025
Same journal

Correction to: Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.

Current topics in behavioral neurosciences·2025
Same journal

Ontologically Challenging Psychedelic Experiences: Considerations for Managing Associated Distress.

Current topics in behavioral neurosciences·2025
Same journal

The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy.

Current topics in behavioral neurosciences·2025
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.9K

Classifying Psychedelic-Related Complications.

Tomislav Majić1,2, Euphrosyne Gouzoulis-Mayfrank3,4, Ricarda Evens5

  • 1Department of Psychiatry and Neurosciences, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany. tomislav.majic@charite.de.

Current Topics in Behavioral Neurosciences
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

Classic psychedelics like psilocybin and LSD show therapeutic promise but also risks. Understanding psychedelic complications is crucial for safe use in therapy and beyond.

Keywords:
AnxietyClassificationDepersonalizationDerealizationHPPDPsychedelicPsychosis

More Related Videos

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K
Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

12.2K

Related Experiment Videos

Last Updated: Feb 28, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.9K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K
Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

12.2K

Area of Science:

  • Neuroscience and Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Classic psychedelics (psilocybin, LSD, 5-MeO-DMT) show therapeutic potential for mental health.
  • Overly optimistic media portrayal has led to increased non-clinical use and complications.
  • Psychedelic risks are often underestimated by professionals and in research.

Purpose of the Study:

  • To provide an overview of complications associated with classic psychedelic use.
  • To discuss the attribution of psychedelic-related disorders to substance use.
  • To consider the classification of psychedelic-related disorders in diagnostic systems.

Main Methods:

  • Review of historical and current classification approaches for psychedelic complications.
  • Analysis of the temporal dynamics of psychedelic effects (acute, subacute, long-term).
  • Discussion of causal links between psychedelic use and disorders.

Main Results:

  • Psychedelic effects unfold over time, with distinct acute, subacute, and long-term phases.
  • A nuanced classification of psychedelic-related risks and harms is needed.
  • Existing classifications may overlook specific psychedelic-related complications.

Conclusions:

  • A comprehensive classification system is essential for assessing psychedelic complications.
  • Understanding temporal dynamics aids in managing risks and maximizing therapeutic benefits.
  • This work provides a framework for safer psychedelic research, therapy, and non-medical use.